6. • EASY OF USE AND
CONVENIENCE
• SAVE TIME
• RAPIDLY EFFECTIVE
• PAINLESS
• NO NEEDLE STICK RISK
• HIGH PATIENT COMPLIANCE
• FASTER CARE AND DISCHARGE
• SAFE TO USE
ADVANTAGES:
7. • LOW BIOAVAILABILITY
• DRUG ELIMINATION
• IRREVERSIBLE DAMAGE TO NASAL
MUCOSA
• DRUG DOSE LOSS DUE TO
IMPROPER USE
• LIMITED DOSE
DISADVANTAGES:
8. THAY ARE USED FOR THE TREATMENT OF
THE FOLLOWING:
• RHINITIS OF COMMON COLD
• VASOMOTOR AND ALLERGIC RHINITIS
INCLUDING HAY FEVER
• SINUSITIS
• CONGESTION
• INFECTIONS
USES:
9. MOST NASAL DECONGESTANT ARE
AQUEOUS PREPARATIONS
THE CONCENTRATION OF ADRENERGIC
AGENTS IN MAJORITY OF NASAL
DECONGESTANTS IS QUITE LOW ABOUT
0.05%-1.0%
NASAL DECONGESTANT
SOLUTIONS:
A DECONGESTANT OR NASAL
DECONGESTANT IS A TYPE OF
PHARMACEUTICAL DRUG THA IS USED
TO RELIVE NASAL CONGESTION IN THE
UPPER RESPIRATORY TRACT.
10. THE ACTIVE INGREDIENT IN
THE NASAL DECONGESTANT
SOLUTIONS ARE EITHER:
• PHENYLEPHRINE
• PSUEODOEPHRINE
• OXYMETAZOLINE
THEY ARE AVAILABLEIN BOTH
ADULTS AND PEDIATRIC(1/2
OF ADULTS STRENGTH) USE
11. • THEY ARE VOLATILE AT ROOM TEMPERATURE.
• THE MEDICATION WHICH HAVE AMINE LIKE
ODOUR IS MASKED WITH ADDED AROMATICS.
• THE INHALERS IN WHICH DRUG IS HELD CONTAIN
CYLINDRICAL ROLLS OF FIBROUS MATERIAL
IMPREGNATED WITH VOLATILE DRUGS,THEY ARE
EFFECTIVE SO LONG.
THE ACTIVE INGREDIENT IN THE INHALERS ARE:
• SALBUTAMOL
DECONGESTANT INHALERS:
12. NASAL SOLUTIONS ARE
USUALLY PACKED IN
DROPPER BOTTLES OR IN
PLASTIC BOTTLE SPRAYS
CONTAINING 15-30ML OF
MEDICATION
PACKAGING: